Aboud, Michael

Top Publications

Top Publications Authored or Co-Authored by "Aboud, Michael"

• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

  The Lancet, Volume 393, No. 10167, Year 2019, Citations 249
• Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

  The Lancet Infectious Diseases, Volume 19, No. 3, Year 2019, Citations 108
• Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

  The Lancet HIV, Volume 4, No. 12, Year 2017, Citations 100
• Dolutegravir-based Antiretroviral Therapy for Patients Coinfected with Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial

  Clinical Infectious Diseases, Volume 70, No. 4, Year 2020, Citations 60
• Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy

  Journal of Antimicrobial Chemotherapy, Volume 74, No. 8, Year 2019, Citations 9